Isobolographic analysis of non-depolarising muscle relaxant interactions at their receptor site

European Journal of Pharmacology

Volumn 438, Issue 1-2, 2002, Pages 35-43

  Paul, Matthias ^a   Kindler, Christoph H ^b   Fokt, Ralf M ^a   Dipp, Natalie C J ^c   Spencer Yost, C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

(Antagonist); Acetylcholine receptor; Interaction; Isobologram; Muscle relaxant; Potency; Xenopus oocyte

Indexed keywords

ACETYLCHOLINE; GALLAMINE; MIVACURIUM; MUSCLE RELAXANT AGENT; NICOTINIC RECEPTOR; PANCURONIUM; POSTSYNAPTIC RECEPTOR; PRESYNAPTIC RECEPTOR; TUBOCURARINE CHLORIDE; VECURONIUM;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BINDING; DRUG EFFECT; DRUG POTENCY; DRUG POTENTIATION; INHIBITION KINETICS; NEUROMUSCULAR BLOCKING; NONHUMAN; OOCYTE; POSTSYNAPTIC INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; XENOPUS LAEVIS;

EID: 0036497377     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)01271-2     Document Type: Article

References (39)

1. What is synergy?
2. Isolation of a clone coding for the alpha-subunit of a mouse acetylcholine receptor
3. Tetanic fade during partial transmission failure produced by non-depolarizing neuromuscular blocking drugs in the cat
4. The acetylcholine receptor: Functional architecture and regulation
5. Mivacurium when preceded by pancuronium becomes a long-acting muscle relaxant
6. Ability of nondepolarizing neuromuscular blocking drugs to act as partial agonists at fetal and adult mouse muscle nicotinic receptors
7. The actions of muscle relaxants at nicotinic acetylcholine receptor isoforms
8. The interaction between d-tubocurarine and gallamine during halothane anaesthesia
9. Synergism between atracurium and mivacurium compared with that between vecuronium and mivacurium
10. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination
11. Additive inhibition of nicotinic acetylcholine receptors by corticosteroids and the neuromuscular blocking drug vecuronium
12. The mechanism of neuromuscular fatigue. A study of mammalian muscle using excitation-contraction uncoupling
13. Potentiation of neuromuscular blockade in man produced by combinations of pancuronium and metocurine or pancuronium and d-tubocurarine
14. Combination of pancuronium and metocurine: Neuromuscular and hemodynamic advantages over pancuronium alone
15. Competitive nonspecific binding does not explain the potentiating effects of muscle relaxant combinations
16. Synergism between atracurium and vecuronium in children
17. Molecular distinction between fetal and adult forms of muscle acetylcholine receptor
18. Isobolographic and dose-response analysis of the interaction between pipecuronium and vecuronium
19. Interactions between mivacurium and atracurium
20. Comparative potency of steroidal neuromuscular blocking drugs and isobolographic analysis of the interaction between rocuronium and other aminosteroids
21. Time course of action of combinations of vecuronium and pancuronium
22. d-tubocurarine binding sites are located at alpha-gamma and alpha-delta subunit interfaces of the nicotinic acetylcholine receptor
23. Interactions between tubocurarine, pancuronium and alcuronium demonstrated in the rat phrenic nerve-hemidiaphragm preparation
24. Synergism between mivacurium and pancuronium in adults
25. The duration of action of mivacurium is prolonged if preceded by atracurium or vecuronium
26. Pre-junctional effects of neuromuscular blocking a facilitatory drugs
27. The pharmacology of flaxedil, with observations on certain analogs
28. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug
29. On the interaction of combinations of nondepolarizing neuromuscular blocking drugs
30. Gamma- and delta-subunits regulate the affinity and the cooperativity of ligand binding to the acetylcholine receptor
31. Pre- and postsynaptic effects of pancuronium at the neuromuscular junction of the mouse
32. Statistical analysis of drug-drug and site-site interactions with isobolograms
33. Nicotinic acetylcholine receptor at 9 A resolution
34. Decrease in dose requirement of d-tubocurarine by volatile anesthetics
35. Quantitative examination of the interaction of competitive neuromuscular blocking agents on the indirectly elicited muscle twitch
36. Interaction among agents that block end-plate depolarization competitively
37. Some synergistic effects of d-tubocurarine and gallamine
38. The magnitude and time course of vecuronium potentiation by desflurane versus isoflurane
39. Potency of agonists and competitive antagonists on adult- and fetal-type nicotinic acetylcholine receptors